CNP Q1 2026 Earnings Slight EPS Miss but Stock Gains on Operational Stability CLDX Q1 2026 Earnings Slight EPS Miss as DevelopmentStage Biotech Continues NoRevenue Phase AMBP Q1 2026 Earnings Strong EPS Beat Amidst Cautious Market Response Tempest Therapeutics Inc TPST Q1 2026 Earnings Significant EPS Miss with No Revenue Stock Edges Up PCTTU Q1 2026 Earnings SmallerthanExpected Loss Amid PreRevenue Operations LTRN Q1 2026 Earnings Narrowed Loss Per Share Beats Estimates as Pipeline Progress Continues